Is a complete JUNS research report available?

No complete published report is available for Jupiter Neurosciences, Inc. (JUNS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Jupiter Neurosciences, Inc. (JUNS)

NASDAQ: JUNS · USD

$2.44

-0.20 (-7.6%)· Recorded snapshot

Market cap	3.2M
Revenue (ttm)	64.7K
Net income (ttm)	-9.2M
EPS (ttm)	-$18.6
Shares out	1.3M
Volume	26,853

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 64.7K
Net income (ttm): -9.2M
EPS (ttm): -$18.6
Market cap: 3.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Giữ

Metric	Value
Amount currency	USD
CIK code	0001679628
Company name	Jupiter Neurosciences, Inc.
Country	United States
Country code	US
CUSIP number	48208B302
Earnings date	2026-11-13
Earnings time	amc
Employees	5
Employees change	1
Employees growth	25%
Enterprise value	$3.4M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2015
Industry	Biotechnology
IPO date	2024-12-03
Is primary listing	Yes
Is SPAC	No
ISIN number	US48208B3024
Last 10-K release date	2026-04-01
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2026-08-07
Last stock split type	Reverse
Market cap	$3.2M
Market cap category	Nano-Cap
Next earnings date	2026-11-13
Options	No
Price	$2.44
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	JUNS
U.S. state	Florida
Website	https://jupiterneurosciences.com

Metric

Value

Amount currency

USD

CIK code

0001679628

Company name

Jupiter Neurosciences, Inc.

Country

United States

Country code

CUSIP number

48208B302

Earnings date

2026-11-13

Earnings time

amc

Employees

Employees change

Employees growth

25%

Enterprise value

$3.4M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2015

Industry

Biotechnology

IPO date

2024-12-03

Is primary listing

Yes

Is SPAC

ISIN number

US48208B3024

Last 10-K release date

2026-04-01

Last earnings date

2026-08-14

Last refreshed

2026-10-28

Last stock split date

2026-08-07

Last stock split type

Reverse

Market cap

$3.2M

Market cap category

Nano-Cap

Next earnings date

2026-11-13

Options

Price

$2.44

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

JUNS

U.S. state

Florida

Website

https://jupiterneurosciences.com

Metric	Value
Earnings yield	-760.97%
EV/Sales	57.32x
FCF / EV yield	-195.5%
FCF yield	-208.27%
Forward EV/Sales	0.3x
Forward P/S	0.28x
P/S ratio	53.81x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-760.97%

EV/Sales

57.32x

FCF / EV yield

-195.5%

FCF yield

-208.27%

Forward EV/Sales

0.3x

Forward P/S

0.28x

P/S ratio

53.81x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Operating margin	-15,166.68%
Pretax margin	-14,220.12%
Profit per employee	$-1.8M
Revenue per employee	$12,939
ROA	-159.56%
ROA (5Y)	-457.98%
ROCE	6,098.14%
ROE	-1,888.7%
ROIC	-420.59%
SBC / revenue	3,803.45%

Metric

Value

Operating margin

-15,166.68%

Pretax margin

-14,220.12%

Profit per employee

$-1.8M

Revenue per employee

$12,939

ROA

-159.56%

ROA (5Y)

-457.98%

ROCE

6,098.14%

ROE

-1,888.7%

ROIC

-420.59%

SBC / revenue

3,803.45%

Metric	Value
EPS growth quarters	1
EPS growth years	0
Net income growth years	0
Revenue growth (QoQ)	29.99%
Revenue growth 5Y	-48.38%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth years

Revenue growth (QoQ)

29.99%

Revenue growth 5Y

-48.38%

Revenue growth years

Metric	Value
EBIT	$-9.8M
EPS	$-18.57
FCF per share	$-5.50
Financing cash flow	$6.9M
Free cash flow	$-7.2M
Free cash flow minus SBC	$-9.7M
Gross profit	$-1.8M
Net borrowing	$5M
Net cash flow	$-356,373
Net income	$-9.2M
Operating cash flow minus SBC	$-9.7M
Operating income	$-9.8M
Revenue	$64,693
Stock-based compensation	$2.5M

Metric

Value

EBIT

$-9.8M

EPS

$-18.57

FCF per share

$-5.50

Financing cash flow

$6.9M

Free cash flow

$-7.2M

Free cash flow minus SBC

$-9.7M

Gross profit

$-1.8M

Net borrowing

$5M

Net cash flow

$-356,373

Net income

$-9.2M

Operating cash flow minus SBC

$-9.7M

Operating income

$-9.8M

Revenue

$64,693

Stock-based compensation

$2.5M

Metric	Value
Altman Z-Score	-18.93
Book value per share	$-0.55
Interest coverage	-35.95
Long-term assets	$1.2M
Long-term liabilities	$205,068
Net cash (debt)	$-227,202
Net cash / market cap	-6.53%
Piotroski F-Score	1
Property, plant and equipment	$219,864
Shareholders' equity	$-365,966
Tangible book value	$-365,966
Tangible book value per share	$-0.55
Total assets	$3.7M
Total cash	$1.5M
Total debt	$1.7M
Total liabilities	$4.1M

Metric

Value

Altman Z-Score

-18.93

Book value per share

$-0.55

Interest coverage

-35.95

Long-term assets

$1.2M

Long-term liabilities

$205,068

Net cash (debt)

$-227,202

Net cash / market cap

-6.53%

Piotroski F-Score

Property, plant and equipment

$219,864

Shareholders' equity

$-365,966

Tangible book value

$-365,966

Tangible book value per share

$-0.55

Total assets

$3.7M

Total cash

$1.5M

Total debt

$1.7M

Total liabilities

$4.1M

Metric	Value
Asset turnover	0.02
Current assets	$2.5M
Current liabilities	$3.9M
Current ratio	0.66
Net working capital	$-1.3M
Quick ratio	0.39
Working capital	$-1.3M
Working capital turnover	-0.11

Metric

Value

Asset turnover

0.02

Current assets

$2.5M

Current liabilities

$3.9M

Current ratio

0.66

Net working capital

$-1.3M

Quick ratio

0.39

Working capital

$-1.3M

Working capital turnover

-0.11

Metric	Value
Buyback yield / dilution	-16.8%
Dividend yield	0%
Shareholder yield	-16.8%

Metric

Value

Buyback yield / dilution

-16.8%

Dividend yield

Shareholder yield

-16.8%

Metric	Value
150-day SMA	$13.83
1D price change	-7.58%
1M price change	-8.61%
1M total return	-8.61%
1W price change	-12.23%
1W total return	-12.23%
1Y price change	-98.09%
1Y return CAGR	-98.09%
1Y total return	-98.09%
20-day SMA	$2.81
200-day SMA	$21.18
3M price change	-71.34%
3M total return	-71.34%
50-day SMA	$3.27
50-day SMA vs 200-day SMA	50under200
52-week high	$135.75
52-week high date	2025-10-28
52-week low	$2.25
52-week low date	2026-10-06
6M price change	-91.03%
6M total return	-91.03%
All-time high	$1,463.25
All-time high date	2024-12-19
All-time low	$2.25
All-time low date	2026-10-06
Average true range (ATR)	$0.35
Average volume	69.1K
Beta (1Y)	0.35
Beta (2Y)	0.21
Change from 52-week high	-98.2%
Change from 52-week low	8.4%
Change from all-time high	-99.83%
Change from all-time low	8.4%
Change from open	-7.92%
Day's gap	0.38%
Dollar volume	$65,521
High price	$2.65
Low price	$2.44
Monthly RSI	8.79
Open price	$2.65
Position in 52-week range	0%
Premarket change	1.52%
Premarket close	$2.64
Premarket price	$2.68
Premarket volume	562
Previous close	$2.64
Price vs 150-day SMA	-82.36%
Price vs 20-day SMA	-13.26%
Price vs 200-day SMA	-88.48%
Price vs 50-day SMA	-25.47%
Relative volume	0.39
Return from IPO open	-99.12%
Return from IPO price	-34%
RSI	37.97
Sharpe ratio	-2.67
Sortino ratio	-3.4
Volume	26.9K
Weekly RSI	25.75
YTD price change	-96.81%
YTD total return	-96.81%

Metric

Value

150-day SMA

$13.83

1D price change

-7.58%

1M price change

-8.61%

1M total return

-8.61%

1W price change

-12.23%

1W total return

-12.23%

1Y price change

-98.09%

1Y return CAGR

-98.09%

1Y total return

-98.09%

20-day SMA

$2.81

200-day SMA

$21.18

3M price change

-71.34%

3M total return

-71.34%

50-day SMA

$3.27

50-day SMA vs 200-day SMA

50under200

52-week high

$135.75

52-week high date

2025-10-28

52-week low

$2.25

52-week low date

2026-10-06

6M price change

-91.03%

6M total return

-91.03%

All-time high

$1,463.25

All-time high date

2024-12-19

All-time low

$2.25

All-time low date

2026-10-06

Average true range (ATR)

$0.35

Average volume

69.1K

Beta (1Y)

0.35

Beta (2Y)

0.21

Change from 52-week high

-98.2%

Change from 52-week low

8.4%

Change from all-time high

-99.83%

Change from all-time low

8.4%

Change from open

-7.92%

Day's gap

0.38%

Dollar volume

$65,521

High price

$2.65

Low price

$2.44

Monthly RSI

8.79

Open price

$2.65

Position in 52-week range

Premarket change

1.52%

Premarket close

$2.64

Premarket price

$2.68

Premarket volume

562

Previous close

$2.64

Price vs 150-day SMA

-82.36%

Price vs 20-day SMA

-13.26%

Price vs 200-day SMA

-88.48%

Price vs 50-day SMA

-25.47%

Relative volume

0.39

Return from IPO open

-99.12%

Return from IPO price

-34%

RSI

37.97

Sharpe ratio

-2.67

Sortino ratio

-3.4

Volume

26.9K

Weekly RSI

25.75

YTD price change

-96.81%

YTD total return

-96.81%

Metric	Value
Float	965.8K
Float percentage	73.25%
Shares change (QoQ)	18.61%
Shares change (YoY)	16.8%
Shares held by insiders	16.67%
Shares held by institutions	5.28%
Shares outstanding	1.3M
Short % of float	3.67%
Short % of shares	2.69%
Short ratio	0.6 days

Metric

Value

Float

965.8K

Float percentage

73.25%

Shares change (QoQ)

18.61%

Shares change (YoY)

16.8%

Shares held by insiders

16.67%

Shares held by institutions

5.28%

Shares outstanding

1.3M

Short % of float

3.67%

Short % of shares

2.69%

Short ratio

0.6 days

Jupiter Neurosciences, Inc. (JUNS)

Price

Financial snapshot

Fair-value bridge

Latest news · JUNS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All JUNS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on JUNS

Frequently asked questions